BDNF and VEGF in the pathogenesis of stress-induced affective diseases: An insight from experimental studies

Pharmacological Reports

Volumn 65, Issue 3, 2013, Pages 535-546

  Nowacka, Marta ^a   Obuchowicz, Ewa ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Affective diseases; Animal models of stress; BDNF; VEGF

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; CATECHOLAMINE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; MESSENGER RNA; SEROTONIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ACUTE STRESS; BEHAVIORISM; BRAIN ATROPHY; BRAIN DERIVED NEUROTROPHIC FACTOR GENE; CHRONIC STRESS; COGNITIVE DEFECT; DEPRESSION; EXPERIMENTAL STUDY; HIPPOCAMPAL CA3 REGION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MOOD DISORDER; NEGATIVE FEEDBACK; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NEUROCHEMISTRY; NONHUMAN; PATHOLOGICAL ANATOMY; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; STRESS;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; DISEASE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; PITUITARY-ADRENAL SYSTEM; STRESS, PSYCHOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84884492736     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(13)71031-4     Document Type: Review

References (103)

1. Allaman I, Papp M, Kraftsik R, Fiumelli H, Magistretti P, Martin JL: Expression of brain-derived neurotrophic factor is not modulated by chronic mild stress in the rat hippocampus and amygdala. Pharmacol Rep, 2008, 60, 1001-1007.
2. Altar CA, Boylan CB, Fritsche M, Jackson C, Hyman C, Lindsay RM: The neurotrophins NT-4/5 and BDNF augment serotonin, dopamine and GAB Aergic systems during behaviorally effective infusions to the substantia nigra. Exp Neurol, 1994, 130, 31-40.
3. Angelucci F, Aloe L, Vasquez PJ, Mathe AA: Mapping the differences in the brain concentration of brainderived neurotrophic factor (BDNF) and nerve growth factor (NGF) in an animal model of depression. Neuroreport, 2000, 11, 1369-1373. (Pubitemid 30262990)
4. Bale TL: Stress sensitivity and the development of affective disorders. Horm Behav, 2006, 50, 529-533. (Pubitemid 44307119)
5. Bergström A, Jayatissa MN, Mørk A, Wiborg O: Stress sensitivity and resilience in the chronic mild stress rat model of depression; an in situ hybridization study. Brain Res, 2008, 1196, 41-52.
6. Berton O, McClung CA, Dileone RJ, Krishnan V, Renthal W, Russo SJ, Graham D et al.: Essential role of BDNF in the misolimbic dopamine pathway in social defeat stress. Science, 2006, 311, 868-878.
7. Binder DK: The role of BDNF in epilepsy and other diseases of the mature nervous system. Adv Exp Med Biol, 2004, 548, 34-56. (Pubitemid 38979612)
8. Binder DK, Scharfam HE: Bran-derived neurotrophic factor. Growth Factors, 2004, 22, 123-131.
9. Binder EB, Nemeroff CB: The CRF system, stress, depression and anxiety-insights from human genetic studies. Mol Psychiatry, 2010, 15, 574-588.
10. Blugeot A, Rivat C, Bouvier E, Molet J, Mouchard A, Zeau B, Bernard C et al.: Vulnerability to depression: from brain neuroplasticity to identification of biomarkers. J Neurosci, 2011, 31, 12889-12899.
11. Bremner JD, Narayan M, Anderson ER, Staib LH, Miller HL, Charney DS: Hippocampal volume reduction in major depression. Am J Psychiatry, 2000, 157, 115-118.
12. Brochington A, Lewist C, Wharton S, Shaw PJ: Vascular endothelial growth factor and the nervous system. Neuropathol Appl Neurobiol, 2004, 30, 427-446. (Pubitemid 39423031)
13. Carmeliet P, Strokebaum E: Vascular and neuronal effect of VEGF in the nervous system: implications for neurological disorders. Cell Dev Biol, 2002, 13, 39-53. (Pubitemid 35418313)
14. Chao HM, Sakai RR, Ma LY, McEwen BS: Adrenal steroid regulation of neurotrophic factor expression in the hippocampus. Endocrinology, 1998, 139, 3112-3118. (Pubitemid 28512338)
15. Chen MC, Hamilton JP, Gotlib IH: Decreased hippocampal volume in healthy girls at risk of depression. Arch Gen Psychiatry, 2010, 67, 270-276.
16. Chiba S, Numakawa T, Ninomiya M, Richards MC, Wakabayashi C, Kunugi H: Chronic restraint stress causes anxiety-and depression-like bahaviors, downregulates glucocorticoid receptor expression, and attenuates glutamate release induced by brain-derived neurotrophic factor in the prefrontal cortex. Prog Neuropsychopharmacol Biol Psychiatry, 2012, 39, 112-119.
17. Christoffel DJ, Golden SA, Russo SJ: Structural and synaptic plasticity in stress-related disorders. Rev Neurosci, 2011, 22, 535-549.
18. Cieślik K, Sowa-Kućma M, Ossowska G, Legutko B, Wolak M, Opoka, Nowak G.: Chronic unpredictable stress-induced reduction in the hippocampal brain-derived neurotrophic factor (BDNF) gene expression is antagonized by zinc treatment. Pharmacol Rep, 2011, 63, 537-543.
19. Connor TJ, Leonard BE: Depression, stress and immunological action: the role of cytokines in depressive disorders. Life Sci, 1998, 62, 583-606. (Pubitemid 28045567)
20. Cross MJ, Claesson-Welsh L: FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition. Trends Pharmacol Sci, 2001, 22, 201-207. (Pubitemid 32244307)
21. Cubała WJ, Godlewska B, Trzonkowski P, Landowski J: Indicators of the persistent pro-inflammatory activation of the immune system in depression. Psychiatr Pol, 2006, 40, 431-444. (Pubitemid 44252116)
22. Cubała WJ, Landowski J: Serotoninergic system and limbic-hypothalamic-pituitary-adrenal axis (LHPA axis) in depression. Psychiatr Pol, 2006, 40, 415-430. (Pubitemid 44252115)
23. Duman RS: Neuronal damage and protection in the pathophysiology and treatment of psychiatric illness: stress and depression. Dialogues Clin Neurosci, 2009, 11, 239-255
24. Duman RS: Role of neurotrophic factors in the etiology and treatment of mood disorders. Neuromolecular Med, 2004, 5, 11-25. (Pubitemid 38391953)
25. Duman RS: Synaptic plasticity and mood disorders. Mol Psychiatry, 2002, 7, S29-S34. (Pubitemid 34280646)
26. Duman RS, Malberg J, Nakaqawa S: Regulation of adult neurogenesis by psychotropic drugs and stress. J Pharmacol Exp Ther, 2001, 299, 401-407. (Pubitemid 32979649)
27. Duman RS, Monteggia LM: A neurotrophic model for stress-related mood disorders. Biol Psychiatry, 2006, 59, 1116-1127.
28. Dwivedi Y: Brain-derived neurotrophic factor: role in depression and suicide. Neuropsychiatr Dis and Treat, 2009, 5, 434-449.
29. Dwivedi Y, Rizavi HS, Pandey GN: Antidepressants reverse corticosterone-mediated decrease in BDNF expression: differental regulation of specific exons by antidepressants and corticosterone. Neurosci, 2006, 139, 1017-1029.
30. Egan MF, Kojima M, Callicot JH, Goldberg TE, Kolachana BS, Bertolino A, Zaitsev E et al.: The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003, 112, 257-269. (Pubitemid 36144114)
31. Fabel K, Fabel K, Tam B, Kaufer D, Baiker A, Simmons N, Kuo CJ, Palmer TD: VEGF is necessary for exerciseinduced adult hippocampal neurogenesis. Eur J Neurosci, 2003, 18, 2803-2812. (Pubitemid 37542133)
32. Ferrara N, Davis-Smyth T: The biology of vascular endothelial growth factor. Endocr Rev, 1997, 18, 4-25. (Pubitemid 27076453)
33. Folkman J, D'Amore PA: Blood vessel formation: what is its molecular basis? Cell, 1996, 87, 1153-1155. (Pubitemid 27010098)
34. Fournier NM, Duman RS: Role of vascular endothelial growth factor in adult hippocampal neurogenesis: implications for the pathophysiology and treatment of depression. Behav Brain Res, 2012, 227, 440-449.
35. Frodl T, Schüle C, Schmitt G, Born C, Baghai T, Zill P, Bottlender R et al.: Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression. Arch Gen Psychiatry, 2007, 64, 410-416. (Pubitemid 46556460)
36. Guilliams TG, Edwards L: Chronic stress and the HPA axis: clinical assessment and therapeutic considerations. Standard, 2010, 9, 1-12.
37. Gould E, Cameron HA: Regulation of neuronal birth, migration and death in the rat dentate gyrus. Deb Neurosci, 1996, 18, 22-35. (Pubitemid 26257906)
38. Gould E, Daniels DC, Cameron HA, McEwen BS: Expression of adrenal steroid receptors by newly born cells and pyknotic cells in the dentate gyrus of the postnatal rat. Mol Cell Neurosci, 1992, 3, 44-48.
39. Gould E, Tanapat P: Stress and hippocampal neurogenesis. Biol Psychiatry, 1999, 46, 1472-1479.
40. Hanson ND, Owens MJ, Nemeroff CB: Depression, antidepressants, and neurogenesis: a critical reappraisal. Neuropsychopharmacology, 2011, 36, 2589-2602.
41. Heine VM, Zareno J, Maslam S, Joëls M, Lucassen PJ: Chronic stress in the adult dentate gyrus reduces cell proliferation near the vasculature and VEGF and Flk-1 protein expression. Eur J Neurosci, 2005, 21, 1304-1314. (Pubitemid 40516629)
42. Herman JP, Ostrander MM, Mueller NK, Fiqueiredo H: Limbic system mechanisms of stress regulation: hypothalamo-pituitary-adrenocortical axis. Prog Neuropsychopharmacol Biol Psychiatry, 2005, 29, 1201-1213. (Pubitemid 41674635)
43. Holsboer F: The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology, 2000, 23, 477-501.
44. Hoshaw BA, Malberg JE, Lucki I: Central administration of IGF-I and BDNF leads to long-lasting antidepressantlike effects. Brain Res, 2005, 1037, 204-208. (Pubitemid 40362398)
45. Howell KR, Kutiyanawalla A, Pillai A: Long-term continuous corticosterone treatment decreases VEGF receptor-2 expression in frontal cortex. PloS One, 2011, 6, e20198.
46. Huang EJ, Reichardt LF: Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci, 2001, 24, 677-736. (Pubitemid 32695243)
47. Jedynak P, Jahołkowski P, Filipkowski RK: Adult neurogenesis and depression. Neuropsychiatr Neuropsychol, 2007, 2, 57-65.
48. Kessler RC: The effects of stressful life events on depression. Annu Rev Psychol, 1997, 48, 191-214. (Pubitemid 127485175)
49. Khaibullina AA, Rosenstein JM, Krum JM: Vascular endothelial growth factor promotes neurite maturation in primary CNS neuronal cultures. Brain Res Dev, 2004, 148, 59-68. (Pubitemid 38147805)
50. Kiuchi T, Lee H, Mikami T: Regular exercise cures depression-like behavior via VEGF-Flk-1 signaling in chronicall stressed mice. Neuroscience, 2012, 207, 208-217.
51. Knapman A, Heinzmann JM, Hellweq R, Holsboer F, Landgraf R, Touma C: Increased stress reactivity is associated with cognitive deficits and decreased hippocampal brain-derived neurotrophic factor in a mouse model of affective disorders. J Psychiatr Res, 2010, 44, 566-575.
52. Lee Y, Duman RS, Marek GJ: The mGlu2/3 receptor agonist LY354740 suppresses immobilization stressinduced increase in rat prefrontal cortical BDNF mRNA expression. Neurosci Lett, 2006, 398, 328-332. (Pubitemid 43673693)
53. Leonard BE: HPA and immune axes in stress: involvement of the serotonergic sysstem. Neuroimmunomodulation, 2006, 13, 268-276. (Pubitemid 47289509)
54. Liu RJ, Aghajanian GK: Stress blunts serotonin-and hypocretin evoked EPSCs in prefrontal cortex: role of corticosterone-mediated apical dendritic atrophy. Proc Natl Acad Sci USA, 2008, 105, 359-364.
55. MacQueen GM, Campbell S, McEwen BS, Macdonald K, Amano S, Joffe RT, Nahmias C, Young LT: Course of illness, hippocampal function, and hippocampal volume in major depression. Proc Natl Acad Sci USA, 2003, 100, 1387-1392. (Pubitemid 36184011)
56. Manji HK, Moore GJ, Rajkowska G, Chen G: Neuroplasticity and cellular resilience in mood disorders. Mol Psychiatry, 2000, 5, 578-593.
57. Maurer MH, Tripps WK, Feldmann RE Jr, Kuschinsky W: Expression of vascular endothelial growth factor and its receptors in rat neural stem cells. Neurosci Lett, 2003, 344, 165-168. (Pubitemid 36694669)
58. McAllister KA: Neurotrophins and neuronal differentiation in the central nervous system. Cell Mol Life Sci 2001, 58, 1054-1060.
59. McCloskey DP, Croll SD, Scharfman HE: Depression of synaptic transmission by vascular endothelial growth factor in adult rat hippocampus and evidence for increased efficacy after chronic seizures. J Neurosci, 2005, 25, 8889-8897. (Pubitemid 41384456)
60. McEwen BS, Eiland L, Hunter RG, Miller MM: Stres and anxiety: structural plasticity and epigenetic regulation as a consequence of stress. Neuropharmacology, 2012, 62, 3-12.
61. Monteggia LM, Luikart B, Barrot M, Theobold D, Malkovska I, Nef S, Parada LF, Nestler EJ.: Brainderived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors. Biol Psychiatry, 2007, 61, 187-197. (Pubitemid 46072778)
62. Murakami S, Imbe H, Morikawa Y, Kubo C, Senba E: Chronic stress, as well as acute stress, reduces BDNF mRNA expression in the rat hippocampus but less robustly. Neurosci Res, 2005, 53, 129-139. (Pubitemid 41219528)
63. Naert G, Ixart G, Maurice T, Tapia-Arancibia L, Givalois L: Brain-derived neurotrophic factor and hypothalamic-pituitary-adrenal axis adaptation processes in a depressive-like state induced by chronic stress. Mol Cell Neurosci, 2011, 46, 55-66.
64. Namiecińska M, Marciniak K, Nowak JZ: VEGF as an angiogenic, neurotrophic, and neuroprotective factor (Polish). Post Hig Med. Dosw, 2005, 59, 573-583.
65. Nemeroff CB, Krishnan KR, Reed D, Leder R, Beam C, Dunnick NR: Adrenal gland enlargement in major depression. A computed tomographic study. Arch Gen Psychiatry, 1992, 49, 384-387.
66. Nibuya M, Takahashi M, Russell DS, Duman RS: Repeated stress increases catalytic TrkB mRNA in rat hippocampus. Neurosci Lett, 1999, 267, 81-84. (Pubitemid 29251591)
67. Nowacka MM, Obuchowicz E: Vascular endothelial growth factor (VEGF) and its role in the central nervous system: a new element in the neurotrophic hypothesis of antidepressant drug action. Neuropeptides, 2012, 46, 1-10.
68. Numakawa T, Yokomaku D, Richards M, Hori H, Adachi N, Kunugi H: Functional interactions between steroid hormones and neurotrophin BDNF. World J Biol Chem, 2010, 1, 133-143.
69. Palazidou E: The neurobiology of depression. Br Med Bull, 2012, 101, 127-145.
70. Parker KJ, Schatzberg AF, Lyons DM: Neuroendocrine aspects of hypercortisolism in major depression. Horm Behav, 2003, 43, 60-66. (Pubitemid 36293275)
71. Pittenger C, Duman RS: Stress, depression and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology, 2008, 33, 88-109. (Pubitemid 350191319)
72. Pizarro JM, Lumley LA, Medina W, Robison CL, Chang WE, Alagappan A, Bah MJ et al.: Acute social defeat reduces neurotrophin expression in brain cortical and subcortical areas in mice. Brain Res, 2004, 1025, 10-20. (Pubitemid 39349520)
73. Rasmusson AM, Shi L, Duman R: Downregulation of BDNF mRNA in the hippocampal dentate gyrus after re-exposure to cues previously associated with footshock. Neuropsychopharmacology, 2002, 27, 133-142. (Pubitemid 34686965)
74. Robinson CJ, Stringer SE: The splice variants of vascular endothelial growth factor (VEGF) and their receptors. J Cell Sci, 2001, 11, 853-865. (Pubitemid 32273121)
75. Roceri M, Hendriks W, Racagni G, Ellenbroek BA, Riva MA: Early maternal deprivation reduces the expression of BDNF and NMDA receptor subunits in the rat hippocampus. Mol Psychiatry, 2002, 7, 609-616.
76. Ruiz de Almodovar C, Lambrechts D, Mazzone M, Carmeliet P: Role and therapeutic potential of VEGF in the nervous system. Physiol Rev, 2009, 89, 607-648.
77. Saarelainen T, Hendolin P, Lucas G, Koponen E, Sairanen M, MacDonald E, Agerman K et al.: Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressantinduced behavioral effects. J Neurosci, 2003, 23, 349-357. (Pubitemid 36050437)
78. Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S, Weisstaub N et al.: Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science, 2003, 301, 805-809. (Pubitemid 36962615)
79. Sapolsky RM: Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry, 2000, 57, 925-935.
80. Sapolsky RM: Stress and plasticity in the limbic system. Neurochem Res, 2003, 28, 1735-1742. (Pubitemid 37296215)
81. Scaccianoce S, Del Bianco P, Caricasole A, Nicoletti F, Catalani A: Relationship between learning, stress and hippocampal brain-derived neurotrophic factor. Neuroscience, 2003, 121, 825-828. (Pubitemid 37324580)
82. Schaaf MJ, de Jong J, de Kloet RR, Vreugdenhil E: Downregulation of BDNF mRNA and protein in the rat hippocampus by corticosterone. Brain Res, 1998, 813, 112-120. (Pubitemid 29012524)
83. Scharfman H, Goodman J, Macleod A, Phani S, Antonelli C, Croll S: Increased neurogenesis and the ectopic granule cells after intrahippocampal BDNF infusion in adult rats. Exp Neurol, 2005, 192, 348-356. (Pubitemid 40347259)
84. Schmidt HD, Duman RS: Peripheral BDNF produces antidepressant-like effects in cellular and behavioral models. Neuropsychopharmacology, 2010, 35, 2378-2391.
85. Segi-Nishida E, Warner-Schmidt JL, Duman RS: Electroconvulsive seizure and VEGF increase the proliferation of neural strem-like cells in the rat hippocampus. Proc Natl Acad Sci USA, 2008, 105, 11352-11357.
86. Shi SS, Shao SH, Yuan BP, Pan F, Li ZL: Acute stres and chronic stres change brain-derived neurotrophic factor (BDNF) and tyrosine kinase-coupled receptor (TrkB) expression in both young and aged rat hippocampus. Yonsei Med J, 2010, 51, 661-671.
87. Shirayama Y, Chen AC, Nakagawa S, Russell DS, Duman RS: Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci, 2002, 22, 3251-3261. (Pubitemid 35379212)
88. Smith MA, Makino S, Kvetnansky R, Post RM: Stress and glucocorticoids affect the expression of brainderived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci, 1995, 15, 1768-1777.
89. Strockmeier CA, Mahajan GJ, Konick LC, Overholser JC, Jurjus GJ, Meltzer HY, Uylings HB et al.: Cellular changes in the postmortem hippocampus in major depression. Biol Psychiatry, 2004, 56, 640-650. (Pubitemid 39446845)
90. Suciak JA, Lewis DR, Wiegand SJ, Lindsay RM: Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). Pharmacol Biochem Behav, 1997, 56, 131-137. (Pubitemid 27016116)
91. Taliaz D, Stall N, Dar DE, Zangen A: Knockdown of brain-derived neurotrophic factor in specific brain sites precipitates behaviors associated with depression and reduces neurogenesis. Mol Psychiatry, 2010, 15, 80-92.
92. Tapia-Arancibia L, Rage F, Givalois L, Arancibia S: Physiology of BDNF: focus on hypothalamic function. Front Neuroendocrinol, 2004, 25, 77-107. (Pubitemid 39582717)
93. Thoenen H: Neurotrophins and activity-dependent plasticity. Prog Brain Res, 2000, 128, 183-191. (Pubitemid 35461235)
94. Ueyama T, Kawai Y, Nemoto K, Sekimoto M, Tone S, Senba E: Immobilization stress reduced the expression of neurotrophins and their receptors in the rat brain. Neurosci Res, 1997, 28, 103-110. (Pubitemid 27267820)
95. Uysal N, Sisman AR, Dayi A, Ozbal S, Cetin F, Baykara B, Aksu I, Tas Aet al.: Acute footshock-stress increases spatial learning-memory and correlates to increases hippocampal BDNF and VEGF and cell numbers in adolescent male and female rats. Neurosci Lett, 2012, 514, 141-146.
96. Vaidya VA, Marek GJ, Aghajanian GK, Duman RS: 5HT2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex. J Neurosci, 1997, 17, 2785-2795. (Pubitemid 27155012)
97. Wagner BM, Compas BE: Gender, instrumentality and expressivity: moderators of the relation between stress and psychological symptoms during adolescence. Am J Commun Psychol, 1990, 18, 383-406.
98. Warner-Schmidt JL, Duman RS: Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment. Hippocampus, 2006, 16, 239-249.
99. Warner-Schmidt JL, Duman RS: VEGF as a potential target for therapeutic intervention in depression. Curr Opin Pharmacol, 2008, 8, 14-19. (Pubitemid 351168696)
100. Warner-Schmidt JL, Duman RS: VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants. Proc Natl Acad Sci USA, 2007, 104, 4647-4652. (Pubitemid 47186279)
101. Webster JI, Tonelli L, Sternberg EM: Neuroendocrine regulation of immunity. Annu Rev Immunol, 2002, 20, 125-163. (Pubitemid 34295785)
102. Wichers M, Maes M: The psychoneuroimmunopathophysiology of cytokine induced depression in humans. Int J Neuropsychopharmacol, 2002, 5, 375-388. (Pubitemid 35470357)
103. Wolkowitz OM, Epel ES, Reus V: Stress hormone-related psychopathology: pathophysiological and treatment implications. World J Biol Psychiatry, 2001, 2, 115-143.